Press Releases

Home / Investor Relations / Press Releases

Language

Category

Year

2024-07-15 12:00 Boule Diagnostics – Invitation to presentation of the interim report Q2 2024

Boule Diagnostics AB will publish the interim report for the period January–June 2024 at 07:30, Monday, July 22nd, 2024. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Torben Nielsen and CFO Holger...

2024-05-08 18:15 Bulletin from the Annual General Meeting May 8, 2024 in Boule Diagnostics AB Regulatory

At the Annual General Meeting 2024 (the "AGM") it was resolved to adopt the profit and loss statement and the balance sheet and the consolidated profit and loss statement and the consolidated balance sheet. The AGM resolved to approve that the company's...

2024-05-08 18:15 Bulletin from the Annual General Meeting May 8, 2024 in Boule Diagnostics AB Regulatory

At the Annual General Meeting 2024 (the “AGM”) it was resolved to adopt the profit and loss statement and the balance sheet and the consolidated profit and loss statement and the consolidated balance sheet. The AGM resolved to approve that the company’s...

2024-05-07 07:30 Boule Diagnostics interim report Q1 2024 Regulatory

Tuesday 7 May 2024

2024-04-30 12:00 Boule Diagnostics – Invitation to presentation of the interim report Q1 2024

Boule Diagnostics AB will publish the interim report for the period January–March 2024 at 07:30, Tuesday, May 7th, 2024. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Torben Nielsen and CFO Holger...

2024-04-16 11:00 Boule Diagnostics publishes the Annual Report for 2023 Regulatory

Boule Diagnostics AB has published the full Swedish Annual Report for the fiscal year 2023 at http://www.boule.com. The annual report is available in English below as a PDF and in Swedish in the European Single Electronic Format (ESEF), printed copies...

2024-04-10 10:00 Torben Nielsen assumes the position as CEO of Boule Diagnostics as of 16 April 2024

As previously announced, Torben Nielsen is appointed new President and CEO of Boule Diagnostics AB. He will assume the position as of 16 April 2024, succeeding Jesper Söderqvist who at the same time leaves Boule Diagnostics AB. Torben Nielsen most recently...

2024-03-14 10:46 New CEO and President at Boule Diagnostics Regulatory

The board of directors at Boule Diagnostics has today appointed Torben Nielsen as the new CEO and President, effective no later than June 14, 2024. Torben Nielsen will replace Jesper Söderqvist, who has been the CEO since 2020. Jesper will be available...

2024-03-04 12:17 Nomination Committee’s proposal for election of Board members 2024

The Nomination Committee of Boule Diagnostics AB has decided to propose to the Annual General Meeting 2024 (AGM) that the number of Board members shall be six, including the Chair. The Nomination Committee proposes re-election of Karin Dahllöf, Thomas...

2024-02-06 07:32 Boule Diagnostics (publ) Year-end report January–December 2023 Regulatory

Solid organic growth and strong operational cash flow Quarter October-December 2023 Full year January-December 2023 *Fund issue elements from the new share issue in Q4 2022 has been taken into account in the calculation of earnings per share before and...

2024-02-01 15:01 Boule Diagnostics – Invitation to presentation of the year-end report 2023

Boule Diagnostics AB will publish the year-end report for the period January–December 2023 at 07:30, Tuesday, February 6th, 2024. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist...

2023-11-09 07:31 Boule Diagnostics (publ) interim report Q3 2023 Regulatory

Increased net sales and positive cash flow Quarter July-September 2023 *Fund issue elements from the new share issue in Q4 2022 has been taken into account in the calculation of earnings per share before and after dilution, which is why the comparative...

2023-11-07 15:01 Boule Diagnostics – Nomination Committee for the 2024 Annual General Meeting

The Annual General Meeting, (”AGM”), 2023 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership structure as per September 30, 2023, will be appointed to propose for the AGM of 2024 the following...

2023-11-06 11:01 Boule Diagnostics – Invitation to presentation of the interim report Q3 2023

Boule Diagnostics AB will publish the interim report for the period January–September 2023 at 07:30, Thursday, November 9th, 2023. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist...

2023-09-14 08:31 Boule signs an agreement for local instrument manufacturing in India

Boule Diagnostics has signed a licensing agreement with Q-Line Biotech for local instrument manufacturing in Uttar Pradesh, India. India is an important market with a projection of over 20,000 hematology systems to be sold each year for the next coming...

2023-07-24 07:31 Boule Diagnostics (publ) interim report April–June 2023 Regulatory

Improved gross margin Quarter April–June 2023 *A bonus issue element from the new share issue in Q4 2022 has been taken into account in the calculation of earnings per share before and after dilutive effects, which means that the comparative figure...

2023-07-20 15:01 Boule Diagnostics – Invitation to presentation of the interim report Q2 2023

Boule Diagnostics AB will publish the interim report for the period January–June 2023 at 07:30, Monday, July 24th, 2023. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist and CFO Jan...

2023-06-29 10:01 Boule Diagnostics today launches new veterinary 5-part hematology solution in Europe

Boule Diagnostics is today launching a new 5-part veterinary solution for cost-effective diagnostics for the European market, the H50V. It is equipped with 13 predefined animal profiles and over 30 analyzed parameters, making it a flexible system that...

2023-06-14 08:02 Boule appoints Holger Lembrér as CFO Regulatory

Boule Diagnostics AB appoints Holger Lembrér as new CFO to take office in January 2024. Holger has a long career in various senior finance positions within the ASSA ABLOY Group. He has a solid financial foundation from being CFO for a business area...

2023-05-04 18:16 Bulletin from Annual General Meeting in Boule Diagnostics AB on May 4, 2023

The Annual General Meeting 2023 (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance sheet for 2022. The AGM resolved that the company's accumulated profits shall be carried forward...

Previous Next